External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

APASL 2025

March 26 - March 30

Beijing, China

apasl.org

Add to calendar

Medical Materials

Agenda

Coming soon

09:00 AM

Duration 24hrs Beijing, China

A novel mechanistic viral dynamics modeling (MVDM) framework to characterize the effect of combination therapies in chronic hepatitis B and evaluate the influence of individual characteristics in the Piranga phase 2 platform study

Claire McGeown

Infectious Disease | Hepatitis B virus infection

Add to calendar

07:30 AM

Duration 10mins Beijing, China

Evaluation of blood droplet volumes on the Cobas Plasma Separation Card for HCV RNA testing in resource-limited settings

Aline Kessler

Infectious Disease | Hepatitis C virus infection

Add to calendar

01:10 AM

Duration 10mins Beijing, China

Efficacy and safety of xalnesiran in combination with the checkpoint inhibitor PD-L1 LNA in virologically suppressed participants with chronic hepatitis B: results from the Piranga phase 2, randomized, controlled, adaptive, open-label platform study

Man-Fung Yuen

Infectious Disease | Hepatitis B virus infection

Add to calendar

01:20 AM

Duration 10mins Beijing, China

Similarities and differences of xalnesiran-based combination regimens aimed to achieve functional cure in the Piranga phase 2 platform study

Rémi Kazma

Infectious Disease | Hepatitis B virus infection

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.